North America In Vitro Diagnostics Market Size Growth to Fuel Lucrative Revenues in the Future

Due to the impact of the Russia-Ukraine conflict and the COVID-19 pandemic, the global economy is expected to recover, leading to an expansion of the World North America In Vitro Diagnostics Market size from USD million in 2021 to USD million in 2022, with a projected CAGR that will generate substantial revenue until 2030. As a result, consumers gain valuable knowledge about the industry and its organizations from past, present, and future perspectives, enabling informed investment decisions and resource allocation. This research report provides up-to-date analysis and forecasts for various market segments and geographical regions. It offers insights and analysis based on in-depth consultations with key stakeholders, including CEOs, Managers.

This extensive report provides an in-depth analysis of the North America In Vitro Diagnostics (IVD) Market. The report covers various aspects, including technology types, applications, end-users, and country-wise segmentation.

Request To Download Free Sample of This Strategic Report:- https://www.reportocean.com/industry-verticals/sample-request?report_id=IR280

Overview of the North America In Vitro Diagnostics Market Research

Report Ocean research report predicts that the North America In Vitro Diagnostics market will experience a Compound Annual Growth Rate (CAGR) of 5.17% during the forecast period from 2019 to 2025. The market has demonstrated consistent growth in recent years, driven by technological advancements and the introduction of innovative products that have boosted the adoption of in vitro diagnostics. Key factors fueling this growth include the increasing incidence of lifestyle and chronic diseases, a rising trend in point-of-care testing (POCT), a surge in biomarker-based tests, and the growing significance of companion diagnostics.

The field of in vitro diagnostics plays a pivotal role in screening, diagnosis, treatment, and monitoring across various medical purposes. Technological advancements continue to revolutionize this sector, with vendors focusing on new product launches, regulatory approvals, and addressing end-users’ perspectives. Major players in the market include Abbott Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Danaher Corporation, and Sysmex Corporation.

Regional Analysis

In 2018, the United States accounted for the largest share of the North America in vitro diagnostics market. The “others” segment is expected to experience a high Compound Annual Growth Rate (CAGR) during the forecast period. Notably, the National Cancer Institute estimates that approximately 1.6 million new cancer cases were diagnosed in the US in 2016, resulting in 595,690 cancer-related deaths. Canada, in the same year, reported an estimated 202,400 new cancer cases and nearly 78,000 cancer-related deaths. The prevalence of lifestyle-related diseases, such as diabetes and heart diseases, poses a significant threat to populations worldwide, with 425 million people suffering from diabetes. Cardiovascular diseases (CVD) account for around 800,000 deaths in the US alone, with one person succumbing to CVD approximately every 40 seconds in the country. Favorable reimbursement policies, the presence of dominant market vendors, increased patient awareness, availability of government funds, and growing adoption of molecular diagnostics collectively make the US a dominant player in the market.

Market Segmentation

The market is segmented based on technology types:

• Clinical Chemistry
• Molecular Diagnostics
• Immunoassay
• Clinical Microbiology
• Coagulation
• Hematology
• Others

In 2018, the clinical chemistry segment held the largest market share, with the molecular diagnostics segment expected to exhibit a high CAGR during the forecast period. Clinical chemistry includes various panels such as metabolic, electrolyte, liver, lipid, renal, thyroid, and specialty chemistry tests. Technological advancements, such as next-generation sequencing and polymerase chain reaction, are expected to propel the molecular diagnostics segment during the forecast period.

Request To Download Free Sample of This Strategic Report:- https://www.reportocean.com/industry-verticals/sample-request?report_id=IR280

Applications

The applications segment includes:

• Oncology
• Infectious Disease
• Diabetes
• Cardiology
• Nephrology
• Autoimmune Disease
• Others

The infectious disease segment dominated the market in 2018, with the oncology segment projected to hold a significant share during the forecast period. The increased prevalence of diseases like tuberculosis and pneumonia, coupled with growing healthcare awareness, positions the infectious disease segment as a dominant shareholder.

End-Users

End-users encompass:

• Hospitals
• Laboratories
• Home Care
• Academic & Research Institutes
• Others

Hospitals held a significant market share in 2018, with both hospitals and laboratories expected to dominate the market in the coming years.

Country Analysis

Countries covered in the report include:

• US
• Others

In 2018, the US held a significant market share, with the “others” segment projected to experience a high CAGR during the forecast period. The United States, with its technological advancements and robust GDP, contributes significantly to the growth of the “others” segment, which includes Canada and Mexico.

Competitive Analysis

The North American in vitro diagnostics market presents significant growth opportunities, intensifying competition among vendors. Technological advancements are a key driver, prompting companies to focus on approvals and collaborations in the in vitro diagnostics sector. For example, Roche launched the VENTANA pan-TRK (EPR17341) Assay in late 2018, capable of detecting tropomyosin receptor kinase (TRK) in multiple solid tumor types. In December 2017, the FDA approved the F1CDx test for identifying genetic alterations in tumors. This genomic test can detect cancer-related alterations in 324 genes in any solid tumor. Additionally, Precision for Medicine acquired ApoCell in late 2018, a next-generation lab specializing in biomarker identification and analysis. Leading players are investing heavily in Research and Development (R&D) activities to develop new products and capture a significant market share.

Request To Download Free Sample of This Strategic Report:- https://www.reportocean.com/industry-verticals/sample-request?report_id=IR280

Key Vendors

• Abbott Laboratories
• F. Hoffmann-La Roche (Roche)
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Sysmex Corporation
• bioMerieux S.A.
• Becton Dickinson and Company
• Bio-Rad Laboratories
• Qiagen N.V.
• Siemens Healthineers
• Ortho Clinical Diagnostics (Carlyle Group)

Key Competitive Facts

• The market is highly competitive, with all players vying for market share. Intense competition, rapid technological advancements, frequent changes in government policies, and pricing considerations are key factors shaping the market.
• High initial investment, implementation, and maintenance costs in the market pose barriers to entry for new players.

Benefits

This report provides comprehensive details about the adoption and usage of in vitro diagnostic products. Stakeholders can gain insights into major trends, drivers, investments, initiatives by key players, and government policies in the in vitro diagnostics sector. Additionally, the report highlights significant challenges that may impact market growth and presents key business opportunities for stakeholders to expand their presence and capture revenue in specific verticals.

Key Takeaways

• Understand the potential market opportunity with precise market size and forecast data.
• Access detailed market analysis focusing on the growth of the in vitro diagnostics industry.
• Explore factors influencing the growth of the in vitro diagnostics market.
• Gain in-depth competitive analysis

Key Questions Answered in the Market Report:

• What are the global trends in the market? Would the market witness an increase or decline in the demand in the coming years?
• What is the estimated demand for different types of products in industry? What are the upcoming industry applications and trends for market?
• What Are Projections of Global Industry Considering Capacity, Production and Production Value?
• What Will Be the Estimation of Cost and Profit?
• What Will Be Market Share, Supply and Consumption? What about Import and Export?
• Where will the strategic developments take the industry in the mid to long-term?
• What are the factors contributing to the final price of market? What are the raw materials used for manufacturing?
• How big is the opportunity for the market? How will the increasing adoption of for mining impact the growth rate of the overall market?
• How much is the global market worth? What was the value of the market in 2023/2022/2021?
• Who are the major players operating in the market? Which companies are the front runners?
• Which are the recent industry trends that can be implemented to generate additional revenue streams?
• What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Industry?

Request full Report :– https://www.reportocean.com/industry-verticals/sample-request?report_id=IR280

About Report Ocean: 

We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel:+1 888 212 3539 (US – TOLL FREE)
Website: https://reportocean.com